scispace - formally typeset
P

Patrick R. Hof

Researcher at Icahn School of Medicine at Mount Sinai

Publications -  834
Citations -  73115

Patrick R. Hof is an academic researcher from Icahn School of Medicine at Mount Sinai. The author has contributed to research in topics: Neocortex & Alzheimer's disease. The author has an hindex of 130, co-authored 796 publications receiving 64987 citations. Previous affiliations of Patrick R. Hof include Albert Einstein College of Medicine & National Institutes of Health.

Papers
More filters
Journal ArticleDOI

Wernicke's area homologue in chimpanzees (Pan troglodytes) and its relation to the appearance of modern human language

TL;DR: The findings support the conclusion that leftward asymmetry of Wernicke's area originated prior to the appearance of modern human language and before the authors' divergence from the last common ancestor and provide the first evidence of covariance between asymmetric of anterior and posterior cortical regions that in humans are important to language and other higher order cognitive functions.
Journal ArticleDOI

Parkinson's Disease-Associated LRRK2 Hyperactive Kinase Mutant Disrupts Synaptic Vesicle Trafficking in Ventral Midbrain Neurons.

TL;DR: It is demonstrated that the enhanced kinase activity resulting from the most frequent G2019S mutation in LRRK2 is the key to this impairment in SV trafficking selectively in MB neurons but not cortical neurons caused by two PARK genes.
Journal ArticleDOI

Staging of cognitive deficits and neuropathological and ultrastructural changes in streptozotocin-induced rat model of Alzheimer’s disease

TL;DR: The data provide a staging of cognitive, structural/ultrastructural, and neuropathological markers in the STZ-icv rat model that in many aspects seems to be generally comparable to stages seen in human sAD.
Journal ArticleDOI

Relative glucose metabolic rate higher in white matter in patients with schizophrenia.

TL;DR: In comparisons of unmedicated schizophrenia patients with normal volunteers, relative metabolic increases are apparent in white matter in patients with schizophrenia as well as decreases in gray matter.